Johnson & Johnson Announces MONARCH™ QUEST 3, Advancing the Latest in Robotically-Assisted Bronchoscopy - Johnson & Johnson
Johnson & Johnson Announces MONARCH™ QUEST 3, Advancing the Latest in Robotically-Assisted Bronchoscopy Johnson & Johnson
Johnson & Johnson Company News
J&J Secures $2.58B Option to Acquire Sail Biomedicines - CGTLive®
J&J Secures $2.58B Option to Acquire Sail Biomedicines CGTLive®
Johnson & Johnson | History, Products, & Controversies - Encyclopedia Britannica
Johnson & Johnson | History, Products, & Controversies Encyclopedia Britannica
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Standout - ChartMill
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Standout ChartMill
J&J hands lymphoma bispecific CAR T back to AbelZeta - BioSpace
J&J hands lymphoma bispecific CAR T back to AbelZeta BioSpace
Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software - MassDevice
Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software MassDevice
Johnson & Johnson (JNJ) Stock Could Trade Below Fair Value While Earnings Look Rich - simplywall.st
Johnson & Johnson (JNJ) Stock Could Trade Below Fair Value While Earnings Look Rich simplywall.st
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Bayer - TradingView
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Bayer TradingView
What The Headline Growth Rate Hides About JNJ Stock - Trefis
What The Headline Growth Rate Hides About JNJ Stock Trefis
Johnson & Johnson $JNJ is Premier Fund Managers Ltd's 8th Largest Position - MarketBeat
Johnson & Johnson $JNJ is Premier Fund Managers Ltd's 8th Largest Position MarketBeat
Johnson & Johnson: Quality, But It Doesn't Deserve A Mid-20s Multiple Right Now - Seeking Alpha
Johnson & Johnson: Quality, But It Doesn't Deserve A Mid-20s Multiple Right Now Seeking Alpha
Governor Shapiro Secures Over $1 Billion Investment from Johnson & Johnson to Build New Cancer-Fighting Manufacturing Facility in Montgomery County, Creating More Than 500 New Jobs - PA Department of Community & Economic Development (.gov)
Governor Shapiro Secures Over $1 Billion Investment from Johnson & Johnson to Build New Cancer-Fighting Manufacturing Facility in Montgomery County, Creating More Than 500 New Jobs PA Department of Community & Economic Development (.gov)
Mirae Asset Global Investments Co. Ltd. Grows Stake in Johnson & Johnson $JNJ - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Stake in Johnson & Johnson $JNJ MarketBeat
The New Engine That Could Power Johnson & Johnson Stock Higher - Trefis
The New Engine That Could Power Johnson & Johnson Stock Higher Trefis
What Johnson & Johnson (JNJ)'s Leadership Shift and Cancer Drug Priority Review Mean For Shareholders - simplywall.st
What Johnson & Johnson (JNJ)'s Leadership Shift and Cancer Drug Priority Review Mean For Shareholders simplywall.st
Exchange Traded Concepts LLC Raises Stock Holdings in Johnson & Johnson $JNJ - MarketBeat
Exchange Traded Concepts LLC Raises Stock Holdings in Johnson & Johnson $JNJ MarketBeat
Confluence Wealth Services Inc. Raises Stock Position in Johnson & Johnson $JNJ - MarketBeat
Confluence Wealth Services Inc. Raises Stock Position in Johnson & Johnson $JNJ MarketBeat
Envestnet Portfolio Solutions Inc. Sells 6,962 Shares of Johnson & Johnson $JNJ - MarketBeat
Envestnet Portfolio Solutions Inc. Sells 6,962 Shares of Johnson & Johnson $JNJ MarketBeat
Sterling Investment Management LLC Has $369,000 Stake in Johnson & Johnson $JNJ - MarketBeat
Sterling Investment Management LLC Has $369,000 Stake in Johnson & Johnson $JNJ MarketBeat
17,243 Shares in Johnson & Johnson $JNJ Bought by Thomasville National Bank - MarketBeat
17,243 Shares in Johnson & Johnson $JNJ Bought by Thomasville National Bank MarketBeat
Why Is Johnson & Johnson (NYSE:JNJ) Advancing Its Robotic Surgery Push? - Kalkine Media
Why Is Johnson & Johnson (NYSE:JNJ) Advancing Its Robotic Surgery Push? Kalkine Media
Johnson & Johnson $JNJ Shares Bought by Interchange Capital Partners LLC - MarketBeat
Johnson & Johnson $JNJ Shares Bought by Interchange Capital Partners LLC MarketBeat
Rydar Equities Inc. Has $3.36 Million Position in Johnson & Johnson $JNJ - MarketBeat
Rydar Equities Inc. Has $3.36 Million Position in Johnson & Johnson $JNJ MarketBeat
Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines - WSJ
Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines WSJ
Merit Financial Group LLC Has $53.25 Million Stock Position in Johnson & Johnson $JNJ - MarketBeat
Merit Financial Group LLC Has $53.25 Million Stock Position in Johnson & Johnson $JNJ MarketBeat
Johnson & Johnson lawsuit: J&J offers up to $5.5 billion to settle baby powder ovarian cancer suits - ABC7 Los Angeles
Johnson & Johnson lawsuit: J&J offers up to $5.5 billion to settle baby powder ovarian cancer suits ABC7 Los Angeles
Johnson & Johnson offers $5.5 billion to settle talc lawsuits - CBS News
Johnson & Johnson offers $5.5 billion to settle talc lawsuits CBS News
Prevail Innovative Wealth Advisors LLC Boosts Position in Johnson & Johnson $JNJ - MarketBeat
Prevail Innovative Wealth Advisors LLC Boosts Position in Johnson & Johnson $JNJ MarketBeat
Enron, Johnson & Johnson, and OpenAI Reveal the Same Disturbing Pattern - inc.com
Enron, Johnson & Johnson, and OpenAI Reveal the Same Disturbing Pattern inc.com
Inside Johnson & Johnson’s Rare Combination: A 64-Year Dividend Streak Meets a 50% Stock Rally - NAI500
Inside Johnson & Johnson’s Rare Combination: A 64-Year Dividend Streak Meets a 50% Stock Rally NAI500
Johnson & Johnson agrees to $5.5B settlement to resolve ovarian cancer talc lawsuits - Top Class Actions
Johnson & Johnson agrees to $5.5B settlement to resolve ovarian cancer talc lawsuits Top Class Actions
Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits - Al Jazeera
Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits Al Jazeera
J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027 - Reuters
J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027 Reuters
Johnson & Johnson Names Tom Cavanaugh to Lead Innovative Medicine Business - citybiz
Johnson & Johnson Names Tom Cavanaugh to Lead Innovative Medicine Business citybiz
Johnson & Johnson Is Becoming A Narrower Company Than You Bought - Trefis
Johnson & Johnson Is Becoming A Narrower Company Than You Bought Trefis
Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings? - Yahoo Finance
Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings? Yahoo Finance
Johnson & Johnson Purchases New Stake in Rapport Therapeutics, Inc. $RAPP - MarketBeat
Johnson & Johnson Purchases New Stake in Rapport Therapeutics, Inc. $RAPP MarketBeat
Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits - WSJ
Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits WSJ
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September - Business Wire
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September Business Wire
People on the Move: Tom Cavanaugh Promoted at Johnson & Johnson as EVP, Worldwide Chairman, Innovative Medicine - BioBuzz
People on the Move: Tom Cavanaugh Promoted at Johnson & Johnson as EVP, Worldwide Chairman, Innovative Medicine BioBuzz